Columbus Circle Investors’s Kindred Biosciences, Inc. KIN Stock Holding History

Columbus Circle Investors’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-70,704	Closed	-$368K	–	322
2015 Q3	$368K	Sell	70,704 -72,853	-51%	-$449K	﹤0.01%	268
2015 Q2	$979K	Buy	143,557 +18,792	+15%	+$133K	0.01%	252
2015 Q1	$891K	Buy	124,765 +51,775	+71%	+$357K	0.01%	265
2014 Q4	$544K	Buy	72,990 +44,961	+160%	+$381K	﹤0.01%	276
2014 Q3	$259K	Sell	28,029 -42,329	-60%	-$572K	﹤0.01%	259
2014 Q2	$1.31M	Buy	+70,358	New	+$1.2M	0.01%	257

Other funds holding KIN

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Columbus Circle Investors's KIN Position: Q4 2015 in Review

Columbus Circle Investors sold out of Kindred Biosciences, Inc. (KIN) in Q4 2015, closing a stake of 70,704 shares — an estimated $368K sold.

Columbus Circle Investors first reported a position in KIN in Q2 2014 and held it in 6 quarters. The position peaked at $1.31M in Q2 2014. 50 funds tracked by Wall St. Rank hold KIN as of Q4 2015.

Columbus Circle Investors reported no remaining Kindred Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
Columbus Circle Investors sold 70,704 Kindred Biosciences, Inc. shares in Q4 2015, an estimated $368K.
Columbus Circle Investors first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 6 quarters.
Columbus Circle Investors's Kindred Biosciences, Inc. position peaked at $1.31M in Q2 2014.
50 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2015.

Based on Columbus Circle Investors's 13F filing for Q4 2015, filed 5 Feb 2016.